LTC4S
Leukotriene C4 synthase
Also known as: LTC4S_HUMAN, MGC33147
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q16873
- Gene
- LTC4S
- Ensembl
- ENSG00000213316
- Chromosome
- 5
- Canonical length
- 150 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins
- Subcellular location
- Nucleoplasm,Endoplasmic reticulum,Cytosol
- Quaternary structure
- Homotrimer
OverviewNCBI Gene
The MAPEG (Membrane Associated Proteins in Eicosanoid and Glutathione metabolism) family includes a number of human proteins, several of which are involved the production of leukotrienes. This gene encodes an enzyme that catalyzes the first step in the biosynthesis of cysteinyl leukotrienes, potent biological compounds derived from arachidonic acid. Leukotrienes have been implicated as mediators of anaphylaxis and inflammatory conditions such as human bronchial asthma. This protein localizes to the nuclear envelope and adjacent endoplasmic reticulum. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
150 residues, UniProt reviewed canonical sequence.
>Q16873|LTC4S
1 MKDEVALLAA VTLLGVLLQA YFSLQVISAR RAFRVSPPLT TGPPEFERVY RAQVNCSEYF
61 PLFLATLWVA GIFFHEGAAA LCGLVYLFAR LRYFQGYARS AQLRLAPLYA SARALWLLVA
121 LAALGLLAHF LPAALRAALL GRLRTLLPWALocalizationUniProt · AlphaFold · HPA
Whether an antibody against LTC4S can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 4
- Mean surface accessibility (rSASA)
- 0.34
- Highest tissue expression
- 12 nTPM
Expression across tissuesHPA
Tissue
- fallopian tube: 12 nTPM
- heart muscle: 11 nTPM
- blood vessel: 9.9 nTPM
- adipose tissue: 7.2 nTPM
- lung: 6.7 nTPM
- adrenal gland: 6.3 nTPM
Single-cell type
- mast cells: 285 nCPM
- microglia: 165 nCPM
- fallopian secretory cells: 77 nCPM
- hofbauer cells: 71 nCPM
- megakaryocytes: 62 nCPM
- hepatic stellate cells: 52 nCPM
Immune cell
- eosinophil: 63 nTPM
- basophil: 20 nTPM
- myeloid DC: 8.6 nTPM
- NK-cell: 4.7 nTPM
- MAIT T-cell: 3 nTPM
- memory CD4 T-cell: 2.1 nTPM
Brain region
- white matter: 11 nTPM
- spinal cord: 6.8 nTPM
- thalamus: 6 nTPM
- medulla oblongata: 5 nTPM
- midbrain: 3.8 nTPM
- cerebellum: 3.7 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.63
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.13
- DepMap mean gene effect
- -0.03
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- leukotriene biosynthetic process
- leukotriene metabolic process
- long-chain fatty acid biosynthetic process
Molecular functions
- enzyme activator activity
- glutathione peroxidase activity
- glutathione transferase activity
- identical protein binding
- leukotriene-C4 synthase activity
- lipid binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of LTC4S in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads LTC4S as an antibody target. Whether an autoantibody or antibody against LTC4S could matter depends on whether native LTC4S is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
LTC4S is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label LTC4S as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...